"10.1371_journal.pone.0150685","plos one","2016-03-07T00:00:00Z","J√≥zsef Prechl; Kriszti√°n Papp; Zolt√°n H√©rincs; Hajna P√©terfy; Veronika L√≥r√°nd; Zolt√°n Szittner; Andone Estonba; Paolo Rovero; Ilaria Paolini; Jokin del Amo; Maria Uribarri; Maria Claudia Alcaro; Otsanda Ruiz-Larra√±aga; Paola Migliorini; L√°szl√≥ Czirj√°k","Diagnosticum Zrt, Budapest, Hungary; MTA-ELTE Immunology Research Group, E√∂tv√∂s Lor√°nd University, Budapest, Hungary; Department of Rheumatology and Immunology, Clinic Center, University of P√©cs, P√©cs, Hungary; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Bilbao, Spain; Department of NeuroFarBa, University of Florence, Florence, Italy; Toscana Biomarkers, Siena, Italy; Progenika Biopharma S.A., a Grifols Company, Derio, Bizkaia, Spain; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy","Conceived and designed the experiments: PR IP MCA LC. Performed the experiments: KP ZH HP ZS AE PM. Analyzed the data: JP KP VL JDA MU. Contributed reagents/materials/analysis tools: PR. Wrote the paper: JP ORL KP LC. Recruited patients: PM VL LC.","J√≥zsef Prechl, Zolt√°n H√©rincs and Hajna P√©terfy are employed by Diagnosticum Zrt, Ilaria Paolini and Maria Claudia Alcaro by Toscana Biomarkers and Jokin Del Amo and Maria Uribarri by Progenika. Paolo Rovero and Paola Migliorini are shareholders of Toscana Biomarkers. J√≥zsef Prechl and Kriszti√°n Papp are inventors of a patent for microarray-based monitoring of antigen specific complement activation (EP2047269B1), which is owned by E√∂tv√∂s Lor√°nd Unniversity and Hungarian Academy of Sciences and is licensed by Diagnosticum zrt. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","03","J√≥zsef Prechl","J√P",15,TRUE,4,6,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
